Nuwellis Inc vs Zillow Group Inc Class A — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Zillow Group Inc Class A trades at $29.87 (market cap $6.59B). The key difference: Zillow Group Inc Class A is far larger — about 2995.5× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 1,361,381). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Zillow Group Inc Class A for 86 Days on average.
| NUWE | ZG | |
|---|---|---|
Market Cap | $2.20M | $6.59B |
Volume | 121,544 | 1,361,381 |
Sector | Health | Media |
52-Week High | $146.65 | $74.58 |
52-Week Low | $0.68 | $27.70 |
Typical Hold Time | 26 Days | 86 Days |
Enterprise Value | -$1.52M | $6.47B |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Zillow Group (ZG) trades at $29.9, up 6.9% over 24 hours, with a mixed technical outlook showing bullish oscillators but bearish moving averages. Fundamentally, the company reported a net income of $23 million in 2025, marking a return to profitability after losses in prior years, supported by revenue growth to $2.58 billion. Analyst sentiment is divided, with a consensus price target of $48.87, though recent news highlights competitive pressures and housing market headwinds.
The stock presents a turnaround opportunity as profitability improves, but risks include sensitivity to interest rates and real estate cycles. With nearly half of analysts rating it a buy, upside exists if execution continues, yet volatility from macroeconomic factors warrants caution for investors seeking stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →